Status Epilepticus
📧 Sign up to get email alerts when something new happens for Status Epilepticus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-05Clinical Trial Update: Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children [Phase 3]
Phase 3 trial comparing intranasal lorazepam versus intravenous lorazepam for control of acute seizures in children has completed. The updat…
-
FDA approval · 2008-09-10FDA Approved: LORAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for lorazepam submitted by Teva Pharmaceuticals USA, Inc., under the existing approval of the dr…
-
FDA approval · 2008-03-18FDA Approved: FOSPHENYTOIN SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for fosphenytoin sodium (ANDA 078476), establishing a generic option for seiz…
-
CLINICAL_TRIALS research · 2007-08-15Clinical Trial Update: Prognosis Factors Associated With Convulsive Status Epilepticus in Adults
This clinical trial update analyzes prognosis factors associated with convulsive status epilepticus in adults, based on completed study data…
-
FDA approval · 2007-08-06FDA Approved: FOSPHENYTOIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original ANDA for fosphenytoin sodium (FOSPHENYTOIN) by Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-08-06FDA Approved: FOSPHENYTOIN SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original ANDA for fosphenytoin sodium, a generic version of the anticonvulsant, manufactured by Hikma Pharmaceuticals USA I…
-
CLINICAL_TRIALS research · 2007-04-02Clinical Trial Update: Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus [Phase 2]
A phase 2 clinical trial update describing the safety and tolerability study of levetiracetam for treating status epilepticus.
-
FDA approval · 2006-11-29FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lorazepam by Hikma Pharmaceuticals USA Inc., authorizing modifications under the supplement.
-
CLINICAL_TRIALS trial_result · 2006-07-21Clinical Trial Update: Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions [Phase 3]
A Phase 3 trial comparing intranasal lorazepam with intramuscular paraldehyde in pediatric convulsions has completed.